Drug
14c Dnl343
14c Dnl343: highest development phase Phase 1, developed by Denali Therapeutics. 1 trial record tracked on RxWires.
- Highest phase
- Phase 1
- Developer
- Denali Therapeutics
Trials
| Drug | Phase | Indication |
|---|---|---|
| [14C]-DNL343 NCT06281158 | Phase 1 | Healthy Volunteers |
Latest
No recent events.
Follow 14c Dnl343 on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.